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Abstract
The current article is a review of the most important and relevant literature published 
in 2016 and early 2017 on non- Helicobacter pylori Helicobacter infections in humans 
and animals, as well as interactions between H. pylori and the microbiota of the stom-
ach and other organs. Some putative new Helicobacter species were identified in sea 
otters, wild boars, dogs, and mice. Many cases of Helicobacter fennelliae and Helicobacter 
cinaedi infection have been reported in humans, mostly in immunocompromised pa-
tients. Mouse models have been used frequently as a model to investigate human 
Helicobacter infection, although some studies have investigated the pathogenesis of 
Helicobacters in their natural host, as was the case for Helicobacter suis infection in 
pigs. Our understanding of both the gastric and gut microbiome has made progress 
and, in addition, interactions between H. pylori and the microbiome were demon-
strated to go beyond the stomach. Some new approaches of preventing Helicobacter 
infection or its related pathologies were investigated and, in this respect, the probiotic 
properties of Saccharomyces, Lactobacillus and Bifidobacterium spp. were confirmed.
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1  | TAXONOMY, PREVALENCE, AND 
DIAGNOSIS OF NON- HELICOBACTER PYLORI  
HELICOBACTER (NHPH) INFECTION
To date, 37 Helicobacter species have been validated. In 2016, some 
new species were proposed as candidates to be added to the growing 
Helicobacter genus. “Helicobacter enhydrae” sp. nov. was isolated from 
the inflamed stomach of southern sea otters.1 A 16S and 23S rRNA 
gene sequence analysis showed that it is closely related to Helicobacter 
mustelae, colonizing the stomach of ferrets. A striking difference be-
tween the two species is the fact that H. mustelae is urease- positive, 
whereas “H. enhydrae” lacks this enzyme which is crucial for gastric 
colonization.2 Another novel urease- negative Helicobacter species, 
“Helicobacter apri” sp. nov., was isolated from the stomach and cecal 
contents of wild boars living in the Apennine Mountains.3 “Helicobacter 
canicola” sp. nov., isolated from canine feces, was previously mis-
identified as Helicobacter cinaedi. However, it exhibited different 
biochemical traits and phylogenetic analyses (16S rRNA, 23S rRNA, 
gyrB, and hsp60 gene sequences), confirmed that this bacterium form 
a distinct cluster.4 A putative novel Helicobacter species, “Helicobacter 
japonicum” sp. nov., was isolated from the stomach and intestines of 
clinically normal mice. This bacillus exhibits in vitro cytolethal distend-
ing toxin (CDT) activity and induces the development of inflammatory 
bowel disease and carcinoma in C57BL/129 IL10−/− mice.5 Rimbara 
et al.6 corrected the draft genome sequence of Helicobacter fennelliae 
strain MRY12- 0050, isolated from a patient with bacteremia. Indeed, 
a putative CDT gene cluster was identified, with the gene products 
sharing 31%, 36%, and 32% amino acid sequence identity with CdtA, 
CdtB, and CdtC of H. cinaedi strain CCUG 18818, respectively.7
Most cats carry Helicobacters in their stomach,8 a finding which 
was confirmed in a recent study in Japan. Kubota- Aizawa et al. 
showed that half of the cats tested were infected with a non- H. pylori 
Helicobacter (NHPH), of which Helicobacter heilmannii sensu stricto 
(s.s.). was the most prevalent species, followed by Helicobacter felis 
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and Helicobacter bizzozeronii. Also in this study, no clear correlation 
was found between infection and gastritis, although gastric carci-
noma was observed in a cat infected with H. heilmannii s.s.9 Although 
it should be noted that the authors did not test for all carnivore 
Helicobacter species, Hong et al.10 described a case of H. felis infec-
tion in a 3 month- old kitten from a research facility, suffering from 
anorexia and occasional vomiting. The prevalence of enterohepatic 
Helicobacter sp. in cats with nonhematopoietic intestinal carcinoma 
(55 cases) was shown to be as high as 56%, and one or more species- 
specific assays were positive for Helicobacter bilis, Helicobacter canis, 
or Helicobacter marmotae. The presence of NHPH was significantly 
associated with large intestinal carcinoma (68%) and mucinous ad-
enocarcinoma (92%).11 Sabry et al. evaluated 149 animals and 10 
human fecal samples for the presence of Helicobacter sp. based on 
16S rRNA gene analysis. NHPH prevalence was 14.8%, while the dis-
tribution among the different animals: sheep, goat, and cattle, was 
26.3%, 3%, and 4.8% respectively. Helicobacter canis was the predom-
inant species detected only in sheep (21%) and goats (3%). Moreover, 
“Helicobacter winghamensis” and Helicobacter canadensis were also 
detected in sheep but not in other animals. In humans, four of 10 pa-
tients were positive and all sequences were identified as H. canis. One 
of these sequences was identical to that of sheep and suggested the 
zoonotic transmission of this pathogen between sheep and humans.12 
Helicobacter trogontum and H. bilis were isolated from the livers of 
aborted sheep fetuses in 20% of cases.13
Many cases of NHPH infection in humans were reported this 
year, mainly H. fennelliae and H. cinaedi in immunocompromised 
patients. H. fennelliae bacteremia was observed in a 73- year- old 
Japanese man, suffering from lung adenocarcinoma and treated 
by platinum- based chemotherapy. Despite antibiotic therapy 
(cefepime, amoxicillin, and doxycycline for 6 weeks), the bacte-
remia reoccurred, most likely due to the long- term damage of the 
enteric mucosa by platinum- based drugs. The man was ultimately 
treated by selective digestive decontamination with kanamycin.14 
Saito et al.15 reported three new cases of H. fennelliae bacteremia 
with gastrointestinal symptoms (nausea, vomiting, and diarrhea), 
and a retrospective study of 24 cases of H. fennelliae bacteremia 
reported in the literature showed that most of the patients had a 
background of immunosuppression, including solid tumors, hemato-
logical malignancies, and autoimmune diseases. A 54- year- old man, 
who underwent a kidney transplant 14 years ago and suffered from 
fever and multifocal cellulitis, was shown to be infected by H. ci-
naedi, which was eradicated by 6 weeks of antibiotic therapy.16 A 
40- year- old woman with systemic lupus erythematosus presented 
with high- grade fever and severe thrombocytopenia, suggesting 
a complication of her disease, and she was finally diagnosed with 
H. cinaedi bacteremia.17 In another case report, a 52- year- old 
Japanese man with a persistent headache and suspected intracra-
nial subdural empyema was diagnosed with H. cinaedi bacteremia 
treated by two neurosurgical drainages and 4 weeks of meropenem 
treatment.18 The first case of cerebral cyst infection by H. cinaedi was 
reported in a 70 year- old man who had a persisting fever for 2 weeks 
prior to hospital admission. An Ommaya reservoir was inserted in a 
cerebral cyst secondary to radiotherapy for parapharyngeal space 
squamous cell carcinoma 10 years before.19 Helicobacter cinaedi was 
also identified in aortic specimen samples from a 49 year- old man 
with an implantable left ventricular assist device who presented with 
the complication of a ruptured infective common iliac aneurysm,20 
in another 49 year- old man with multiple myeloma and autologous 
stem cell transplantation who had febrile diarrhea and malakopla-
kia,21 in the urine of a 77 year- old man on hemodialysis admitted for 
feverishness and penile pain with urination,22 and in a 38 year- old 
Japanese man with X- linked agammaglobulinemia complicated by re-
current cellulitis for 2 years.23 Another patient with agammaglobulin-
emia had a refractory bacteremia with fever and erythema extended 
to both legs, caused by H. cinaedi, which was resistant to penicillins 
and cephalosporins during prolonged treatment. Intravenous treat-
ment with imipenem/cilastatin and minocycline for 2 weeks pursued 
by oral minocycline for 2 months eliminated symptoms, although 
a stool sample was still positive for H. cinaedi.24 A 54- year- old im-
munocompetent Japanese man who was found to have bacteremia 
complicated with bilateral lower extremity cellulitis due to H. cinaedi 
had two recurring episodes post- treatment; therefore, treatment was 
prolonged (12 weeks) until his symptoms subsided.25 The H. cinaedi 
cinaedi atherosclerosis inflammatory protein (CAIP) antigen partic-
ipates in atherosclerotic inflammation by promoting macrophage 
differentiation into foam cells and drives a pro- inflammatory Th1 
phenotype, an immunopathological response associated with athero-
sclerosis.26 Schmitz et al.27 showed that in vitro growth of H. cinaedi 
could be enhanced by coculture with human epithelial cells (Caco- 2, 
LS- 174T, AGS, and HeLa) and l- lactate supplementation under H2- 
free aerobic conditions.
Diagnosis of Helicobacter suis infection is often problematic, mainly 
due to the extremely difficult isolation of this bacterium. Indeed, in 
vitro isolation of H. suis from infected humans has so far been un-
successful and the few human isolates available have always been 
maintained in vivo via mouse passaging. Interestingly, Matsui et al.,28 
for the first time, determined the whole- genome sequence from a 
mouse- passaged H. suis strain, obtained from a Japanese patient 
with nodular gastritis. In contrast to some other Helicobacter species, 
different gastric NHPH species cannot be easily identified by mere 
16SrRNA gene sequence analysis; this was confirmed by Puri et al.29 
who analyzed hundreds of Helicobacter 16S rRNA gene sequences 
from 45 different Helicobacter species. Detection of H. suis infection 
in humans has thus far only been possible by molecular methods, but 
the available PCR assays occasionally cross- react with host DNA or 
DNA from other Helicobacter species. Blaecher et al.30 developed a 
highly sensitive and specific probe- based RT- PCR assay and an opti-
mized protocol to isolate low numbers of H. suis from infected mice. 
Both methods may help to detect and isolate H. suis from humans in 
the future. Detection of H. suis and other gastric NHPH in gastric tis-
sue is also possible in routine histology and immunohistochemistry, 
although not up to the species level. Fernandez- Flores et al.31 demon-
strated that an anti- Treponema antibody also stains gastric NHPH. 
This cross- reactivity indicates that immunohistochemical staining re-
sults should be interpreted with caution. A method was developed to 
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identify five enterohepatic Helicobacter species (H. bilis, Helicobacter 
rodentium, Helicobacter muridarum, Helicobacter typhlonius, and 
Helicobacter hepaticus) with nested PCR followed by high- resolution 
melting curve analysis.32
2  | PATHOGENESIS OF NON HELICOBACTER 
PYLORI  HELICOBACTER INFECTIONS
For a long time, the lack of H. suis in vitro culture has hampered re-
search on the pathogenesis of infection. Recently, H. suis strains were 
isolated in vitro from the stomach of rhesus monkeys and crab- eating 
macaques. Similar to pig- associated H. suis strains,33 these primate- 
associated H. suis strains were shown to induce severe gastric inflam-
mation in mice and Mongolian gerbils, which was accompanied by 
a marked Th17 response and increased CXCL- 13 levels, which may 
play a role in the development of typical lymphoid lesions associated 
with H. suis infection.34 These same authors characterized, for the 
first time, the inflammation in the stomach of H. suis- infected pigs.35 
Similar to the mouse model, increased IL- 17 expression levels were 
observed in infected animals. In contrast to mice, however, stimula-
tion with H. suis resulted in semi- maturation of moDC, which skewed 
the immune response toward a Treg- biased response. Previous stud-
ies have shown that H. suis not only induces an immune response, but 
also interacts with gastric epithelium. Zhang et al.36 showed that this 
bacterium closely interacts with porcine gastric acid- producing pari-
etal cells, affecting the health as well as the function of this cell type.
To understand how H. cinaedi could be translocated after passage 
through the intestinal mucosa and induced bacteremia, a preclinical 
animal model was developed. Male BALB/c mice were inoculated 
orally with a human H. cinaedi strain. The organism persistently col-
onized (at least 56 days) the mouse intestinal tracts, particularly the 
cecum and colon. The inoculated bacteria were recovered from the 
spleen, liver, kidneys, lungs, bladder, and mesenteric lymph nodes 
during the first 2 weeks of bacteremia, but not after 4 weeks.37
Helicobacter hepaticus colonization is substantially increased in the 
ileum of BALB/c mice with vitamin D deficiency and high fat feeding. 
Oral administration of alpha 5 defensin restored eubiosis and showed 
eradication of H. hepaticus.38
Helicobacter bilis infection of C3H/HeN mice harboring the altered 
Schaedler flora (ASF) induced the development of colitis associated 
with temporal changes in composition and spatial distribution of the 
mucosal microbiota. Adherent biofilms in colitic mice were composed 
of total bacteria, ASF457, and H. bilis in the majority of samples.39
Various mouse models were implemented to investigate NHPH 
infection. Male lamellipodin KO mice, infected with Helicobacter 
species (mainly by H. typhlonius and H. hepaticus), developed rec-
tal prolapse and lesions consistent with invasive rectal carcinoma 
unlike uninfected mice.40 In 129/SvEv RAG2−/− mice, the CDT of 
H. hepaticus was not involved in cecal colonization but increased 
the severity of cecal pathology: preneoplastic dysplasia progressed 
to cancer after 10 to 20 weeks postinfection. The CDT increased 
the number of lower bowel intestinal γH2AX- positive epithelial 
cells (a double- stranded DNA break marker) and transcriptional 
upregulation of cecal TNFα and IL- 6 was also observed, as well as 
phospho- STAT3 foci+ intestinal crypts, suggesting that CDT pro-
motes H. hepaticus carcinogenesis by enhancing DNA breaks and 
activation of the TNFα/IL- 6- STAT3 signaling pathway.41 To examine 
whether conversion of Th17 cells into Th1- like cells is necessary 
for immunopathology, a H. hepaticus typhlocolitis model was used. 
In C57BL/6J IL17ACre or RAG1Cre mice, no Th1- like IFNγ+ ex- Th17 
cells were induced during H. hepaticus infection. Despite the lack 
of these cells, the degree of H. hepaticus- triggered intestinal in-
flammation in mice did not differ from control mice.42 Helicobacter 
hepaticus-infected C57BL/6 RAG−/−CD11ccreIL10RAfl/fl mice with 
a CD11c- specific deletion of the IL- 10 receptor alpha developed 
severe large intestinal inflammation with infiltrating T cells and in-
creased levels of IL- 17a, IFNγ, and IL- 12p40. These results demon-
strate that IL- 10 control of CD11c+ myeloid cells is essential to the 
maintenance of immune homeostasis in the small and large intestine 
and protection against H. hepaticus- induced colitis.43 Helicobacter 
hepaticus infection of RAG2- deficient mice induces high levels of 
IL- 22,44 as well as the expression of iNOS and the development 
of DNA double- stranded breaks, depending on iNOS activity, es-
pecially in proliferating crypt epithelial cells, and development of 
dysplasia. Depletion of the H. hepaticus- induced cytokine IL- 22 in-
hibited these effects.45
3  | HELICOBACTER FELIS  INFECTION 
OF MICE AS A MODEL FOR HUMAN 
H. PYLORI  INFECTION
In the past, experimental infection of mice with H. felis was often used 
as a surrogate model for human Helicobacter (pylori) infection, and this 
was also the case in 2016. In line with what Bosschem et al. showed 
for H. suis,34 Chonwerawong et al.46 found that the host background 
has a profound impact on the susceptibility to Helicobacter- induced 
pathologies. In a Th2- polarized BALB/c mouse model, the Th1 cy-
tokine IFN- γ was shown not to be required for host defense against 
experimental H. felis infection, although it was important for lymphoid 
aggregate formation.
Experimental infection of mice on a Th1- prone C57BL/6 back-
ground with H. felis is often performed to study Helicobacter-induced 
carcinogenesis. Helicobacter felis- infected Myd88−/− mice previously 
showed an accelerated progression to gastric dysplasia compared to 
wild- type mice.47 Global transcriptome analysis in the same mouse 
model revealed upregulation of chitinase- like 4, involved in tissue re-
modeling and wound healing, as well as other genes involved in gastric 
cancer progression.48
Nardilysin is a metalloendopeptidase promoting ectodomain shed-
ding of various growth factors and cytokines. Kimura et al.49 showed 
that deletion of nardilysin in mice with a CBA background resulted 
in attenuation of metaplastic changes induced by H. felis infection, 
most likely due to the profound role of nardilysin, in regulating gastric 
inflammation.
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4  | TREATMENT AND PREVENTION 
OF NON HELICOBACTER PYLORI  
HELICOBACTER INFECTIONS
The search for new therapeutics targeting Helicobacter sp. and re-
lated gastric pathologies also continued in 2016. Hexane extracts of 
Callophylum brasiliense, an evergreen tree native to Latin America’s 
rain forests, were shown to attenuate H. felis- induced gastric epi-
thelial pathology,50 and crude N- acetylneuraminic acid obtained 
from glycomacropeptide (G- NANA) of whey was shown to possess 
anti- Helicobacter activity, reducing H. felis colonization levels in 
mice.51 Administration of Saccharomyces boulardii to H. suis- infected 
mice resulted in increased H. suis- specific IgA levels in gastric juice, 
lower bacterial colonization levels, and reduced formation of gas-
tric lymphoid follicles, which are typically induced by chronic H. suis 
infection.52
Some NHPH, in particular “Helicobacter apodemus,” Helicobacter 
cholecystus, and H. rodentium, were significantly more abundant 
during pregnancy of Sprague Dawley rats. Antibiotic treatment (azi-
thromycin or cefaclor) significantly reduced the relative abundance 
of Helicobacters, and the effect was more marked in non- pregnant 
animals.53 In mice with a deficiency in intestinal proteoglycan 
(mucin2), the classic triple antibiotic therapy (amoxicillin, clarithro-
mycin, and metronidazole) had negative effects on reproductive per-
formance and could not eradicate NHPH while in vitro fertilization 
with embryo transfer was effective.54 All 11 Helicobacter pullorum 
isolates from broiler and free- range chickens sampled from retail wet 
markets were resistant to multiple antibiotic classes, that is, fluo-
roquinolones, cephalosporins, sulfonamides, macrolides, and clavu-
lanic acid. Comparative genomic analysis of these isolates revealed 
the presence of antimicrobial resistance genes, a significant preva-
lence of prophages, and the presence of genomic islands.55 Three 
new Helicobacter prophages were identified in H. hepaticus (ATCC 
51449), Helicobacter cetorum (MIT 99- 5656), and H. bizzozeronii 
(CIII- 1). The prophage phiHBZC1_1 of H. bizzozeronii harbors a gene 
highly similar to emrD encoding the multidrug resistance protein D 
of Salmonella enterica subsp. enterica serovar Infantis.56 NHPH iso-
lates from cheese, milk, milking equipment, tanks, cheese ripening 
chambers, and sinks in small enterprises involved in the production 
of cow’s milk and the manufacture of goat cheese, showed biocide 
tolerance and had a sulfonamide resistance gene.57 The abundance 
of Helicobacters was significantly increased after 2 weeks of a lactu-
lose treatment, mainly in the cecal mucus (72%) in C57BL/6J mice.58 
Also, the quest for an H. pylori vaccine is ongoing. Using an H. felis 
and H. pylori mouse model, Moyat et al.59 showed that IL- 22 has a 
critical role in vaccine- induced protection. This effect was shown not 
to depend on the pro- inflammatory properties of IL- 22, but rather on 
the increased expression of antimicrobial peptides, such as RegIIIb, 
capable of killing Helicobacter. Future research should determine 
the true value of these potential novel strategies for the prevention 
and treatment of Helicobacter infection- related diseases and should 
continue to focus on the emergence of antimicrobial resistance.
5  | GASTRIC AND GUT MICROBIOTA
The application of high- throughput next- generation sequencing 
(NGS) has spearheaded the study of the human gastric microbiome to 
enhance our understanding of the microbiota residing in our stomach. 
It is now established that the human stomach is a niche environment 
colonized by specialized and unique gastric microbiota represented 
by Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes, and 
Fusobacteria as the major phyla in both adults and children.60-62 
Among H. pylori- positive patients, this species dominates the mucosa- 
associated microbiota.62,63 However, the role of conventional cultur-
ing techniques in the studying of gastric microbiota should also not be 
undermined. Indeed, besides H. pylori, bacteria belonging to various 
genera have been isolated in vitro from gastric juice or gastric mu-
cosa. These include Streptococcus spp., Neisseria spp., Klebsiella spp., 
Lactobacillus spp., Escherichia coli, Rothia sp., Burkholderia pseudomal-
lei, Bacillus sp., Morganella morganii, Acinetobacter sp., Haemophilus 
sp., Veillonella sp., Clostridium sp., Bacteroides sp., Corynebacterium sp., 
and Peptococcus sp.63-65 Recently, a strain of a Gram- positive, faculta-
tive anaerobic and nonmotile coccus isolated from gastric lavage of a 
patient was sequenced. Based on phenotypic and genomic analysis, 
the validation of Streptococcus timonensis as a new member of the 
Streptococcus genus has been proposed.66 Actual isolation of micro-
bial members of the human gastric microbiota enables in vitro and in 
vivo studies to be carried out to extend our knowledge of the gastric 
microbiota.
Studying monozygotic twins provides a unique opportunity to de-
termine whether the gastric microbiome is influenced more heavily 
by genetics or by the environment. Analysis of the gastric microbiome 
of four pairs of monozygotic twins with dyspepsia and eight gender- 
and age- matched unrelated individuals from Qingdao (China) demon-
strated interpersonal variations in richness and evenness even among 
co- twins with a similar genetic background. Thus, exogenous factors 
(such as diet, medication, lifestyle, and environment) rather than host 
genetic factors may play more important roles in shaping the gastric 
microbiome of individuals.67
Several studies investigated the effects of H. pylori on the gastric 
microbiome in symptomatic pediatric patients. A study characterized 
the gastric microbiome of 51 pediatric patients with dyspeptic symp-
toms (18 H. pylori positive and 33 negative) from Madrid, Spain.62 
Brawner et al. compared 45 children and 41 adults with chronic symp-
toms and H. pylori infection in Santiago (Chile) and showed that the 
overall gastric microbiota composition of H. pylori- positive children 
differed significantly from that of H. pylori- negative children and that 
of adults (regardless of H. pylori status).68 Therefore, acquisition of 
H. pylori early in life might have played a bigger role in shaping our gas-
tric microbiome composition than acquiring the bacterium later in life.
Beyond taxonomical knowledge, it is at least as important to un-
derstand functions of the interaction between H. pylori and the gastric 
microbiome. Brawner et al.68 further reported that, in H. pylori- positive 
children, FOXP3, IL-10, and TGFβ expressions were elevated and this 
is consistent with increased Treg cell responses, which is important for 
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differentiating between self and foreign antigens. Thus, H. pylori might 
persist in the stomach during early life by promoting immunological toler-
ance and downregulating gastric inflammation, which is consistent with 
reduced gastric disease severity in H. pylori- positive children compared 
to H. pylori- positive adults. Liquid chromatography- coupled tandem 
mass spectrometry- based proteomics was used to study the interactions 
between H. pylori and members of the gastric microbiota or host envi-
ronment. Khosravi et al.69 demonstrated interactions between H. pylori 
and Streptococcus mitis, which is commonly found in the human stomach. 
By analyzing the proteome along different sites of the gastrointestinal 
tract (including the stomach) of germ- free, Bacteroides thetaiotaomicron 
monocolonized and conventionally raised mice, Lichtman et al.70 showed 
that the presence of gut microbiota substantially impacted the proteomic 
profile of the stomach of mice. Unlike most studies of similar nature that 
rely on sequencing variable regions of 16S rRNA gene, Schulz et al. used 
a reverse- transcribed 16S rRNA gene that has the advantage of capturing 
only transcriptionally active bacteria. In 24 adult patients from Germany, 
it was found that the presence of H. pylori exerts significant influences 
on the microbiome of duodenum and oral cavity and consequently may 
influence the development of duodenal diseases.63
In addition to H. pylori, recent studies implied that Streptococcus sp. 
and Prevotella sp. may also be functionally active in the gastric microbi-
ota. The effect of omeprazole, a proton- pump inhibitor (PPI) commonly 
used as part of anti- H. pylori eradication regimens, on the gastric micro-
biome was studied. Notably, Firmicutes, particularly Streptococcus sp., 
increased significantly after PPI treatment in both H. pylori- negative and 
H. pylori- positive patients.71 Tseng et al. conducted a 2- year follow- up 
study on 6 early- stage cancer patients in Taiwan to characterize the ef-
fects of subtotal gastrectomy on the gastric microbiome. Streptococcus 
sp and Prevotella were the two most abundant genera after surgical 
treatment of gastric cancer and predicted gene functions from 16S 
rRNA gene sequencing showed a shift from N- nitrosation genes prior 
to surgery to bile salt hydrolase, NO, and N2O reductase, which reflect 
the altered gastric environment after the surgery.72 Further studies to 
determine the clinical implications of elevated numbers of Streptococcus 
sp. in the stomach in health and disease are necessary.
Numerous observations suggest that chronic microbial coloniza-
tion can impact the immune control of other unrelated pathogens. 
Possible interactions between Mycobacterium tuberculosis infec-
tion and Helicobacter persistence have been investigated in mice. 
Compared with Helicobacter- free mice, M. tuberculosis infection of 
H. hepaticus- infected mice triggers a modification of the gut microbi-
ota, a stimulation of innate immunity, hypercytokinemia, accumulation 
of activated T cells, senescent cells, which results in severe lung tissue 
injury.73 These findings suggest that the impact of prior Helicobacter 
colonization and subsequent M. tuberculosis parasitism might be 
greater than previously thought. In a mouse model for chronic psy-
chosocial stress, which promotes a microbial signature of gut inflam-
mation (characterized by expansion of Proteobacteria, specifically 
Helicobacter sp.), the presence or absence of exposure to Helicobacter 
sp. during the experiment contributed to the variability of results be-
tween laboratories.74 Ffar2, a receptor for short- chain fatty acids, me-
tabolites of dietary fiber fermentation by gut microbiota, is essential 
for the elimination of H. hepaticus from gut microbiota and for the sup-
pression of colonic inflammation and carcinogenesis.75
Probiotics are living microorganisms which have health benefits on 
the host when administered in adequate amounts.76 Nakae et al., in a 
study on 44 healthy controls and 44 functional dyspepsia (FD) patients 
in Japan, found that significant dysbiosis with a reduced abundance of 
Prevotella sp. in their gastric juice was associated with FD. A significant 
inverse correlation was reported between an abundance of Prevotella 
sp. and severity of postprandial distress- like syndromes and treatment 
of FD patients with a yogurt containing a probiotic strain of Lactobacillus 
gasseri daily for a 12- week period reversed the dysbiosis and relieved 
their symptoms.77 The administration of probiotics for correction of gas-
tric dysbiosis may be a rational and promising direction for the treatment 
of FD. However, the microbiota of gastric aspirates is distinct from that 
in mucosal biopsies and does not provide a reliable representation of the 
mucosal- associated bacteria.63 In addition, the evaluation of symptoms 
of FD by Nakae et al. was questionnaire- based; hence, this might be 
subjective and cannot entirely rule out a placebo effect.
In another study, Helicobacteraceae decreased with a probi-
otic cocktail (Lactobacillus acidophilus, Bifidobacteria bifidum, and 
Bifidobacteria infantum) in a rat model of colon cancer. This probiotic 
treatment altered the gut microbiota by promoting the growth of 
Lactobacilli to the detriment of other bacteria and reduced cancer via 
TLR2 signaling.78 Prebiotic feeding (galacto- oligosaccharides) resulted 
in a decreased abundance of Helicobacters in wild- type 129 mice.79 
C57BL/6J mice with high fat diet had a dysbiosis characterized by 
a dramatic increase of bacteria belonging to the Helicobacter genus. 
Treatment with quercetin reversed this effect, suggesting a prebiotic 
capacity.80 Sodium butyrate treatments mitigated in vitro ammonia 
generation and decreased the relative abundance of Helicobacter sp. 
in the cecal contents of laying hens.81 Helicobacter sp was found to 
be decreased in the presence of laminarin or sodium alginate in a rat 
model82 and taurine reduced the abundance of Proteobacteria, espe-
cially Helicobacters in BALB/c mice.83
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